|
PRESS RELEASES
Contacts:
Anthony
Viscogliosi, Small Bone Innovations, Inc.
(212) 583-9700 ext. 100
Nick Kilsby, Creative Partners,
(203) 705-9202, Cell: 203-829-6400
SMALL BONE INNOVATIONS,
INC. TO PARTICIPATE AT THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
2007 ANNUAL MEETING
Small Bone & Joint Leader Marking Its 2nd Birthday at the 2007 AAOS
- Booth #2532 at the San Diego Convention Center
- Tuesday morning 2/13/07 First Albany Capital presentation
- Tuesday evening 2/13/07 Magnifi Group “Magnificent Seven”
Sponsor &
Presenter
- Wednesday evening 2/14/07 UNI-Elbow™ Instructional Course
New York, NY: February 12, 2007 - Small Bone Innovations, Inc.
(SBi), a single-source provider of innovation, products, technology
and education for the small bone & joint sector of the orthopedic
industry, will have another major presence at this year’s American
Academy of Orthopaedic Surgeons (AAOS) 2007 Annual Meeting, February
13-18, in San Diego, California. Over 14,000 medical professionals are
expected to attend this year’s Meeting, with exhibits from over
400 companies from around the world.
With an anatomical focus from the “finger to the shoulder”
and the “toe to below the knee,” SBi continues to serve
the significant unmet clinical needs of small bone & joint orthopedic
surgeons and their patients. With an extensive and expanding U.S. and
Outside the U.S. product portfolio, (fully on display at Booth # 2532
in the San Diego Convention Center, 9:00am to 5:00pm, Wednesday, February
14th through Friday, February 16th), SBi is committed to becoming the
worldwide leader in the design, development, and marketing of arthroplasty,
internal and external fixation systems, and tissue repair technology,
in the form of implants and related medical devices.
“There is no place like the American Academy of Orthopaedic Surgeons
annual meeting,” said SBi Founder, Chairman & CEO, Anthony
G. Viscogliosi. “The musculoskeletal/orthopedic community consistently
places the needs of the patient first and foremost with every device
they design, technique they develop, and educational class they teach.
Small Bone Innovations, Inc. strives each day to follow that blueprint,
and we are honored to participate at the AAOS annual meeting for the
third year in a row, especially since this year’s meeting marks
SBi’s second birthday.”
FIRST ALBANY CAPITAL ORTHOPEDIC CONFERENCE
Small Bone Innovations, Inc. Founder, Chairman & CEO, Anthony G.
Viscogliosi, will be presenting at the First Albany Capital 2nd Annual
Orthopedic conference on Tuesday, February 13, 2007, at 8:10am Pacific
time. Mr. Viscogliosi will be available during a breakout session, immediately
following his presentation, at 8:30am. The conference is being held
at the Marina Village Conference Center in San Diego, California.
Speaking about the First Albany Capital conference, Mr. Viscogliosi
said, “Judging from this year’s line-up of impressive public
and private presenting companies, it promises to be a tremendous event.
Small Bone Innovations had a record-setting year on many fronts in 2006.
I look forward to sharing with the FAC attendees, the great strides
we made to serve small bone & joint surgeons and their patients,
as well as many of the exciting plans we have for 2007.”
THE MAGNIFICENT 7
On Tuesday, February 13, 2007 at 5:30pm Pacific time, Small Bone Innovations
will be one of seven global orthopedic companies to participate in a
ground-breaking event, as The Magnifi Group, featuring their patent-pending
3D Interactive Technology Platform, will host over 140 leading orthopedic
surgeons for a surgical techniques presentation. SBi Founder, Chairman
& CEO Anthony G. Viscogliosi will be on hand to introduce SBi Corporate
Medical Advisory Board Chairman and World-renowned surgeon, Dr. William
Cooney, Professor Emeritus, Rochester, Minnesota’s Mayo Clinic.
Dr. Cooney will be presenting the SBi RE-MOTION™ Total Wrist System
- an anatomically designed implant requiring no resection of the distal
radius.
This invitation-only event, featuring guest speaker and legendary Chicago
Bears player and coach, Mike Ditka, will be held at San Diego’s
Manchester Grand Hyatt Hotel.
Commenting on The Magnificent 7 event, Mr. Viscogliosi said, “It
is truly remarkable to think that in only 2 short years, Small Bone
Innovations, Inc. has created an entire industry – The Small Bone
& Joint Industry. And now, we are proud to share the stage at this
prestigious event with the likes of Stryker, Smith & Nephew, DePuy
Spine and Biomet. It all goes to show that there has always been an
unmet need to address the diseases of the upper and lower limbs, and
the global orthopedic community has finally taken notice of something
we began to address years ago.”
UNI-ELBOW™ INSTRUCTIONAL COURSE
Dr. Bernard F. Morrey, Professor of Orthopedics, Mayo Clinic College
of Medicine, will lead the SBi UNI-Elbow™ Radio Capitellum System
Instructional course entitled “Surgical Techniques & Short
Term Results for Radio Capitellum Resurfacing Procedure” on Wednesday
evening, February 14, 2007 from 6:00pm to 8:00pm Pacific time at the
Omni San Diego Hotel. A buffet dinner will be provided.
Mr. Viscogliosi, speaking about the SBi instructional course, said,
“The SBi UNI-Elbow™ Radio Capitellum System is designed
specifically for Uni-Compartmental Arthroplasty. The implant is indicated
for degenerative joint diseases, the correction of functional deformities,
for revision procedures where other treatments have failed, and for
treatment of fractures that are unmanageable using other techniques.
Particularly when used with SBi’s Precise Guidance Technology™
(PGT) Instrumentation, a proprietary instrument system designed to facilitate
correct anatomical placement and a simple, easy to follow technique,
small bone & joint surgeons will find this elbow system to be extremely
advantageous to the patients and their practice. We could not have a
found a better advocate for our UNI-Elbow™ than someone as accomplished
and distinguished as Dr. Morrey.”
* * * * * * * * * * * * *
About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi
Bros., LLC, (VB), the New York-based merchant banking firm that specializes
in the musculoskeletal /orthopedic sector. VB created SBi as the first
company to focus purely on small bone & joint science. By integrating
established companies and professionals in the field, SBi today offers
a broad, clinically proven portfolio of products and technologies to
treat trauma and diseases in small bones & joints.
VB’s acquisitions and technology licenses include: Avanta
Orthopaedics (hand/wrist/elbow arthroplasty and trauma products
– USA); Envision (implant manufacturing
– USA); Actipore™ (porous
metal technology – Canada); Artelon®
(biologically active & biodegradable technology – Sweden);
Xtremi-T (resorbable trauma technology
– USA); and Fixano, S.A.S. (broad
line of small bone & joint implants - France).
SBi completed a Series B financing, raising a record total of $42.2
million, announced in January, 2006. Based on data provided by Venture
Source, this was the largest venture capital investment ever recorded
in the field of orthopedic devices. SBi was a 2006 recipient of Red
Herring magazine’s annual “Red Herring 100 North America”
award, recognized as one of the nation’s leading technology companies
and the only orthopedic device company selected among an initial entry
of more than one thousand firms. Additionally, SBi’s Artelon CMC-I
Spacer, developed for patients with thumb base osteoarthritis, was featured
on the cover and highlighted within Medical Design Technology magazine’s
“Year of Innovation” issue as one of the most fascinating
technologies influencing the medical device industry.
For more information on SBi, please visit: www.totalsmallbone.com
Forward-looking statements
This press release may contain forward-looking statements as defined
in the U.S. Private Securities Litigation Reform Act of 1995. Readers
are cautioned not to place undue reliance on these forward-looking statements.
Actual results may differ materially from those indicated by these forward-looking
statements as a result of risks and uncertainties impacting the Company's
business including increased competition; the ability of the Company
to expand its operations and to attract and retain qualified professionals;
technological obsolescence; general economic conditions; and other risks.
> Back to Press Releases
|
|
